Bionano Genomics Stock Investor Sentiment
| BNGO Stock | USD 3.05 0.03 0.99% |
About 53% of Bionano Genomics' investors are presently thinking to get in. The analysis of overall sentiment of trading Bionano Genomics stock suggests that some investors are interested at this time. Bionano Genomics' investing sentiment overview a quick insight into current market opportunities from investing in Bionano Genomics. Many technical investors use Bionano Genomics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 53
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bionano Genomics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bionano Genomics.
News SentimentNeutral | Hype SentimentNeutral | Insider SentimentAcquiring |
Bionano Historical Sentiment
Although Bionano Genomics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bionano, such as negative comments on social media and news outlets, may cause fear in the market and push Bionano Genomics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bionano.
Bionano Genomics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Bionano Genomics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Bionano Genomics' Stock prices. Below is the latest headlines and news related to Bionano Genomics Stock. The global stock market is bullish. About 67% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Bionano Genomics that are available to investors today. This information is accessible both publicly - through Bionano Genomics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Bionano-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Bionano Genomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bionano Genomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bionano Genomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bionano Genomics alpha.
Bionano Largest EPS Surprises
Earnings surprises can significantly impact Bionano Genomics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-04 | 2021-09-30 | -0.06 | -0.07 | -0.01 | 16 | ||
2021-08-04 | 2021-06-30 | -0.05 | -0.06 | -0.01 | 20 | ||
2023-03-09 | 2022-12-31 | -0.11 | -0.13 | -0.02 | 18 | ||
2022-08-04 | 2022-06-30 | -0.09 | -0.11 | -0.02 | 22 | ||
2022-03-01 | 2021-12-31 | -0.06 | -0.08 | -0.02 | 33 | ||
2020-11-12 | 2020-09-30 | -0.05 | -0.08 | -0.03 | 60 |
There is far too much social signal, news, headlines, and media speculation about Bionano Genomics that are available to investors today. This information is accessible both publicly - through Bionano Genomics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Bionano-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Bionano Genomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bionano Genomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bionano Genomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bionano Genomics alpha.
Bionano Genomics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 402 shares by Jonathan Dixon of Bionano Genomics at 1.27 subject to Rule 16b-3 | 05/08/2025 |
2 | Bionano Genomics Inc Q1 2025 Earnings Call Highlights Navigating Revenue Challenges ... | 05/15/2025 |
3 | Disposition of 3568 shares by Mark Oldakowski of Bionano Genomics at 0.48 subject to Rule 16b-3 | 05/27/2025 |
4 | Acquisition by Adamchak Mark of 3029 shares of Bionano Genomics at 3.47 subject to Rule 16b-3 | 05/30/2025 |
5 | Disposition of tradable shares by Jonathan Dixon of Bionano Genomics at 3.69 subject to Rule 16b-3 | 06/03/2025 |
6 | Bionano Genomics, Inc. Short Interest Update | 06/06/2025 |
7 | Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the ... | 06/18/2025 |
8 | What drives Bionano Genomics Inc. stock price - Free Stock Market Mentorship - Jammu Links News | 07/18/2025 |
9 | What drives Bionano Genomics Inc. stock price - Rapid capital growth - Autocar Professional | 07/21/2025 |
10 | Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium | 07/30/2025 |
11 | When is Bionano Genomics Inc. stock expected to show significant growth - Free Stock Insights For Every Investor - jammulinksnews.com | 08/01/2025 |
12 | Bionano Genomics announces release of latest versions of its VIA, Solve BNGO | 08/05/2025 |
Check out Bionano Genomics Hype Analysis, Bionano Genomics Correlation and Bionano Genomics Performance. To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bionano Genomics. If investors know Bionano will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bionano Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (53.53) | Revenue Per Share | Quarterly Revenue Growth (0.26) | Return On Assets | Return On Equity |
The market value of Bionano Genomics is measured differently than its book value, which is the value of Bionano that is recorded on the company's balance sheet. Investors also form their own opinion of Bionano Genomics' value that differs from its market value or its book value, called intrinsic value, which is Bionano Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bionano Genomics' market value can be influenced by many factors that don't directly affect Bionano Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bionano Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bionano Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bionano Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.